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Ocular  enucleation  leads  to  NF-B  activation  in the  superior  colliculus.
NF-B  subunits  p65  and  p50  protein  levels  increased  after  visual  system  deafferentation.
Dexamethasone  was  able  to  attenuate  NF-B  activation  in  the  superior  colliculus.
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a  b  s  t  r  a  c  t
Ocular  enucleation  produces  signiﬁcant  morphological  and  physiological  changes  in  central  visual  areas.
However,  our  knowledge  of the  molecular  events  resulting  from  eye  enucleation  in  visual  brain  areas
remains  elusive.  We  characterized  here  the  transcription  nuclear  factor  kappa-B  (NF-B)  activation
induced  by ocular  enucleation  in  the  rat  superior  colliculus  (SC).  We  also  tested  the  effectiveness  ofeywords:
ye enucleation
F-B
examethasone
isual pathways
the  synthetic  glucocorticoid  dexamethasone  in  inhibiting  its activation.  Electrophoretic  mobility  shift
assays  to  detect  NF-B  indicated  that  this  transcription  factor  is activated  in the  SC from  1  h to  day  15
postlesion.  The  expression  of  p65  and  p50  proteins  in  the  nuclear  extracts  was  also  increased.  Dexam-
ethasone  treatment  was  able  to  signiﬁcantly  inhibit  NF-B  activation.  These  ﬁndings  suggest  that  this
transcriptional  factor  is  importantly  involved  in  the visual  system  short-term  processes  that  ensue  after
t  braretinal  lesions  in  the adul
. Introduction
The nuclear factor kappa-B (NF-B) is a transcriptional regulator
ith a central role in inducing genes involved in neuronal plas-
icity, development, survival and inﬂammation. Five NF-B family
embers have been described in mammals: p50 (NF-B1), p65
RelA), p52 (NF-B2), c-Rel and RelB. These NF-B family mem-
ers are capable to form various homodimeric and heterodimeric
omplexes that can exert positive and negative effects on target
ene transcription [9,35]. As described in recent reviews [9,19,29],
ctivation of NF-B requires the phosphorylation, ubiquitination
nd subsequent degradation in the proteosome of its inhibitory
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subunit, known as IB (IB, IB, IB, IB BCL-3, IkBNS, p100,
and p105, which are typiﬁed by the presence of multiple ankyrin
repeat domains). The activated NF-B dimer translocates to the
nucleus and binds with high afﬁnity to DNA B sites with the 5′-
GGGRNWYYCC-3′ sequence in promoters and enhancers of target
genes. Termination of the transcriptional response depends not
only on resynthesis of typical IB proteins, but also on the removal
of active NF-B dimers from the DNA [9,35].
NF-B inﬂuences the expression of a complex array of genes in
the nervous system, including those coding for cytokines, such as
tumor necrosis factor (TNF) and interleukin-6 [18,30], BCl family
molecules [8], cyclooxygenase-2 (COX-2) [11], cell surface recep-
tors [4] and antioxidant enzymes such as manganese superoxide
dismutase [5]. The inducible form of nitric oxide synthase [18,13]
is also an important target gene for NF-B. Although the progress
in understanding the mechanisms that stimulate NF-B activation
has been undeniably remarkable in many regions of the nervous
system, our knowledge of the roles of this transcription factor
Open access under the Elsevier OA license.in the visual system remains underappreciated. Thus, consider-
ing the limited data available so far and the potential importance
in understanding how this multifunctional transcription factor is
involved in visual system physiological and pathological processes,
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he experiments described here were designed to directly test the
ffect of unilateral eye enucleation upon NF-B activation in the
at superior colliculus (SC). In addition, we investigated the effect
f the synthetic glucocorticoid dexamethasone (DEX) on that phe-
omenon.
. Materials and methods
.1.  Animals
Nine week-old male Wistar rats, weighing between 180 and
00 g, were used throughout this study. Animals were singly
oused and maintained on a 12:12 h light/dark cycle. All procedures
ere approved by the Institutional Animal Care Committee of the
nstitute of Biomedical Sciences, University of São Paulo (protocol
umber 017/2007).
.2.  Unilateral enucleation
The  animals were anesthetized with ketamine hydrochloride
5 mg/100 g of body weight, i.m.) and xylazine (1 mg/100 g of body
eight, i.m.). Eye enucleation was performed by dissection of
eriorbital tissue with a scissor, resecting the optic nerves and
ompletely removing the right eye. A piece of absorbable gelatin
Gelfoam, Upjohn, Kalamazoo, MO,  USA) was placed inside the
rbit for better healing, the eyelids were sutured to prevent bleed-
ng, and the animals were returned to the animal facility. Animals
sed for electrophoretic mobility shift assay (EMSA) were sacriﬁced
n = 40) after different survival times, namely 1 h and 1, 7, 10, 15,
nd 30 days after unilateral enucleation. An additional group of rats
n = 25) were unilaterally enucleated and treated with dexametha-
one (DEX) and their brains were also used in EMSA experiments.
ntact animals were used as control groups.
.3. Electrophoretic mobility shift assay to NF-B consensus
ligonucleotide
After the appropriate survival time, the animals were decapi-
ated, the brains were removed and SC samples were immediately
xtracted under visual control after removal of the overlying cor-
ical tissue. The SC samples approximately included the tissue
n the dorsal brainstem from the bregma coordinates −5.52 to
7.57 [22], and were frozen in liquid nitrogen and stored at −70 ◦C
ntil use. Each SC was homogenized using a Dounce homoge-
izer in cold PBS supplemented with 0.5 mM DTT, 0.5 mM  PMSF,
 Lg/mLl leupeptin, 2 lg/mL antipain, and 3 mM sodium ortho-
anadate and centrifuged at 48 C for 30 s at 12,000 × g. Pellets
ere resuspended in lysis buffer (10 mM HEPES, pH 7.9, 1.5 mM
gCl2, 10 mM KCl, 0.1 mM  EDTA, 0.5 mM PMSF, 2 g/mL leu-
eptin, 2 g/mL antipain, 3 mM sodium orthovanadate, 30 mM
odium ﬂuoride, 20 mM sodium pyrophosphate) and incubated
n ice for 10 min. After the addition of NP-40 (0.5%), samples
ere mixed and centrifuged for 30 s at 13,000 × g. Nuclei were
esuspended in extraction buffer (20 mM HEPES, pH 7.9, 25% glyc-
rol, 1.5 mM MgCl2, 300 mM NaCl, 0.25 mM  EDTA, 0.5 mM PMSF,
 g/mL leupeptin, 2 g/mL antipain), incubated for 20 min  on ice
nd centrifuged for 20 min  at 13,000 × g at 4 ◦C. The remaining
upernatants containing nuclear proteins were stored at −80 ◦C.
rotein concentration was determined using the BioRad protein
eagent. EMSA for NF-B was performed using a gel shift assay
it from Promega [29]. NF-B double-stranded consensus oligonu-
leotide (5′-AGTTGAGGGGACTTTCCCAGGC-3′) was  end-labeled
ith -32P-ATP using T4 polynucleotide kinase. Unincorporated
ucleotides were removed by passing the reaction mixture
hrough a Sephadex G-25 spin column (Amersham-Pharmacia,
ppsala,  Sweden). Puriﬁed 32P-labeled probe (30,000 cpm) was Letters 521 (2012) 104– 108 105
incubated  in 20 L with 5 g nuclear extracts in a binding reac-
tion mixture containing 50 mM NaCl, 0.2 mM EDTA, 0.5 mM  DTT,
4% glycerol, 10 mM Tris–HCl (pH 7.5) and 0.05 g poly(dI–dC)
for 30 min  at room temperature. DNA–protein complexes were
separated by electrophoresis through a 6% non-denaturing
acrylamide:bis-acrylamide (37.5:1) gel in 0.5× Tris–borate/EDTA
(TBE) for 2 h at 150 V. Gels were vacuum-dried and ana-
lyzed by autoradiography. For competition experiments, NF-B
and TFIID (5′-GCAGAGCATATAAGGTGAGGTAGGA-3′) unlabeled
double-stranded consensus oligonucleotide was included in 2-fold
molar excess over the amount of 32P-NF-B probe in order to
detect speciﬁc and non-speciﬁc DNA–protein interactions, respec-
tively. The composition of the complexes was determined by
supershift assays; antibodies (1:10 dilution) against different NF-
B subunits (p50 and p65) were added before the incubation of
nuclear extracts with the labeled oligonucleotide. Autoradiograph
quantiﬁcation was  performed with Image J (National Institutes of
Health/USA).
2.4. Immunoblotting
In  order to detect the presence of the p50 and p65 in nuclear
extracts seven days after ocular enucleation, animals were decap-
itated, the brains were removed and the SC samples were quickly
collected as described above. These samples were frozen in liq-
uid nitrogen and stored at −70 ◦C until use. Nuclear extracts were
prepared as described above. Seventy-ﬁve micrograms of total pro-
tein in Laemmli buffer were boiled for 5 min  and separated by 8%
acrylamide SDS gels (Bio-Rad, San Diego, CA, USA) at 25 mA and
electrophoretically transferred to nitrocellulose membranes (Mil-
lipore, Billerica, MA,  USA) at 100 V for 80 min  using a Trans-Blot cell
system (Bio-Rad, San Diego, CA, USA). The membranes were then
blocked for 2 h at room temperature with phosphate buffered saline
(PBS) containing 0.05% Tween-20 (TTBS) and 5% non-fat milk, and
incubated overnight at 4 ◦C with antibodies against p50 and p65
(1:500; Santa Cruz, Biotechnology, CA, USA). The probed proteins
were developed by using a chemiluminescent kit (ECL, Amersham
Biosciences, EUA).
2.5.  DEX treatment
The  eye-enucleated animals received daily injections of DEX
(1 mg/kg i.p.), a synthetic glucocorticoid with anti-inﬂammatory
properties [1], starting immediately after the lesion and for the next
2 consecutive days. DEX was dissolved in saline and thus the con-
trol groups received saline injections. Seven days after the lesion
the brains were used for EMSA assays.
2.6. Determination of blood glucose
Since a single dose of DEX may  signiﬁcantly induce glucose intol-
erance [31], hyperinsulinemia and hyperglycemia [24,3], tail blood
samples of treated and non-treated rats were collected for mea-
surement of blood glucose levels using a glucometer (One-touch
Ultra, Johnsons and Johnsons, Milpitas, CA, USA).
2.7. Statistical analysis
Values  are expressed as means ± S.E.M. Statistical comparisons
were performed by one-way ANOVA, followed by Tukey’s multiple
comparison tests. Values of p ≤ 0.05 were considered signiﬁcant.
Data from the contralateral side of the brain to the removed
eye were always compared to data obtained from intact animals.
The number of rats (n) used in each group is referred to in the
legends.
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. Results
.1. Electrophoretic mobility shift assay to NF-B consensus
ligonucleotide
As  evaluated by EMSA, ocular enucleation signiﬁcantly
ncreased  NF-B DNA binding activity in nuclear extracts of the
ontralateral SC from 1 h to day 15 (ca. 216–254%) postlesion, how-
ver 30 days postlesion there was no signiﬁcant activation of NF-B
Fig. 1A and B). Supershift analysis indicated that the p65 subunit
ntibody shifted DNA/protein complex interactions found in SC
uclear extracts. In contrast, p50 subunit antibody did not affect
NA–protein complex. These results suggest that the p65 subunit
as possibly the major NF-B component that is present in nuclear
xtracts of SC samples (Fig. 1D). The NF-B/DNA complex was
isplaced by an excess of unlabeled NF-B, but not by TFIID dou-
le stranded oligonucleotide consensus sequence, demonstrating
he speciﬁcity of NF-B/DNA binding interaction of this complex
Fig. 1D). DEX treatment was able to inhibit the NF-B activation
y 44% (Fig. 2).
ig. 1. Effects of ocular enucleation upon NF-B activation in the SC. Densit-
metric  analysis of the NF-B bands obtained from nuclear extracts of SC (A,
 = 5 in each case) *p < 0.01 and **p < 0.001 vs control. The position of speciﬁc
F-B/DNA  binding complex is indicated in panel B, which is representative of
ifferent timepoints of NF-B activation in SC nuclear extracts: 1 h, 1, 7, 15 and
0  days postlesion. The presence of the p65 and p50 subunits and the effect
f  ocular enucleation on their levels were revealed by means of immunoblot-
ing  assays (C, n = 3). Competition studies (D, n = 4) were performed using nuclear
xtracts  from SC 7 days postlesion in the absence or presence of unlabeled (NF-
B consensus sequence 5-fold molar excess) or non-speciﬁc oligonucleotide (TFIID
onsensus sequence 20-fold molar excess), as indicated. Supershift assays were
lso performed in the absence or presence of antibodies against subunits p50
nd  p65. NS represents non-speciﬁc binding. The localization of the probe is also
ndicated. Letters 521 (2012) 104– 108
3.2. Immunoblotting
Immunoblotting data revealed the presence of both p65 and
p50 subunits in SC nuclear extracts. It was also possible to
detect the increased expression of both proteins 7 days postle-
sion. The basal p50 protein expression seems to be much smaller
than p65 expression (Fig. 1C). These results suggest that the
NF-B complex in the deafferented SC is also composed of p50
subunits.
3.3. Determination of blood glucose
Our results indicated that the blood glucose levels (n = 6–7 sam-
ples in each case) were not signiﬁcantly altered after DEX treatment
(85.6 ± 2.2, 82.4 ± 1.8, 87 ± 2.5, 84.9 ± 1.9 mg/dL for control, con-
trol + DEX, deafferented and deafferented + DEX, respectively).
4. Discussion
The rodent visual system provides a suitable model to study
the impact of the retinal afferents on the functional organization
of the central visual areas. Experimental manipulation of retinal
outputs, such as crush and section of the optic nerve, leads to
degeneration of retinal ganglion cells [21] and to morphological
alterations in the visual centers of the brain. The subcortical visual
system is comprised of a large number of retinorecipient nuclei,
including the lateral geniculate complex, the pretectal nuclei, the
superior colliculus (SC), the accessory optic nuclei and hypothala-
mic areas [2]. In rats, the SC represents the major primary retinal
projection area, receiving approximately 65% of the contralateral
retinal ganglion cell projections [32]. This represents a major rea-
son why  several studies have addressed the electrophysiological,
morphological and biochemical changes in the SC induced by uni-
lateral eye enucleation [15,28]. However, our knowledge of the
molecular events resulting from eye enucleation in the SC remains
elusive.
As evaluated by EMSA, the present study demonstrates that
eye enucleation leads to a transient NF-B activation in the SC. In
agreement with our results, there is an extensive literature regard-
ing NF-B activation in several regions of the nervous system. For
instance, NF-B activity is increased after seizure activity [7], in a
rat model of amyloid-beta-induced Alzheimer’s disease [38] and
after lesions of the spinal cord [17]. However, only a limited num-
ber of reports have addressed the role of this transcription factor
in the visual system. A study carried out in monkeys revealed
that monocular enucleation does not change p65 expression in
nuclear fractions of primary visual cortex. This observation is also
supported by the absence of degradation of the NF-B cytoplas-
mic anchoring protein IB [14]. In contrast, a recent report has
also described that retinal ganglion cells under hypoxia exhibited
increased NF-B activation and IB phosphorylation/degradation
[33].  The functional signiﬁcance of the NF-B activation in the SC
after retinal removal is still unclear. As this transcription factor
acts broadly inﬂuencing gene expression events that impact cell
survival, it is likely to contribute to the intense plastic activity
occurring after such lesions, even in adult animals, a hypothesis
that remains yet to be directly tested.
Among a variety of different stimuli, it is particularly impor-
tant to mention glutamate as well as reactive oxygen species
(ROS) as relevant inducers of NF-B activation [6], since they have
been described in retinorecipient structures after retinal lesions
[20,23,10]. Although this study did not include an attempt to estab-
lish a direct relationship between glutamate and ROS on NF-B
activation, these data may  lead to the speculation that both could
be involved in NF-B activation after retinal removal.
M.S. Hernandes et al. / Neuroscience Letters 521 (2012) 104– 108 107
Fig. 2. Effects of DEX treatment on NF-B activation in the SC. Normalized densitometric data of the NF-B bands obtained from nuclear extracts of animals allowed to
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[urvive for 7 days postlesion (A, n = 4 in each case). *p < 0.05 (control vs experiment
f  NF-B bands. NS, non-speciﬁc binding.
Although supershift assay analysis indicated that p65 homod-
mer was possibly the major DNA–protein complex present in
uclear extracts of SC samples, we further characterize the expres-
ion of NF-B protein subunits by means of immunoblotting.
nalysis  of nuclear extracts showed that both p65 and p50 protein
evels markedly increased seven days after the lesion, suggest-
ng that the NF-B complex is mainly composed of p65 subunits,
lthough p50 is also present [12].
DEX is a synthetic glucocorticoid with anti-inﬂammatory prop-
rties [1]. The mechanistic basis of the anti-inﬂammatory actions of
lucocorticoids remains poorly understood, but accumulating evi-
ence suggests that these effects largely result from inhibition of
ignal-dependent transcription factors that mediate inﬂammatory
rograms of gene activation such as those involving NF-B [16].
lthough most of these studies have been limited to inﬂammatory
ells such as macrophages and lymphocytes in vitro, the ability of
EX in suppress NF-B activation is considered to be a predominant
echanism by which it exerts its anti-inﬂammatory effects [36]. A
roposed mechanism involves IB inhibitory protein transcription
nduction, which reduces the amount of NF-B that translocates to
he nucleus [26]. In the present study, when administered daily
ver the course of 3 days, DEX was able to signiﬁcantly inhibit
F-B activation. Similarly, other studies have demonstrated that
EX treatment signiﬁcantly attenuates LPS-induced NF-B DNA-
inding activity in the rat cortex [37] and experimentally induced
eizures in the rat cortex and hippocampus [34]. Furthermore, DEX
an selectively inhibit p65 subunit expression when administered
efore LPS and kainate in rat striatal primary neuronal cultures [27].
t is noteworthy that the DEX doses administered in the present
tudy were not able to alter glucose levels. Similarly, 12 days of
EX treatment (1 mg/kg) did not alter the plasma glucose levels in
ats [25].
The  ﬁndings of the present study indicate that the removal of
etinal ganglion cell input leads to a transient NF-B activation
nto SC, and therefore to a neuroinﬂammatory process. This was
onﬁrmed by the fact that systemic injections of DEX effectively
locked NF-B activation. Immunoblotting and EMSA data suggest
hat the NF-B complex in the deafferented SC is mainly composed
f p65 subunits, although p50 is also present. In summary, these
esults are likely to integrate with several other advances in the
nowledge of adult visual system damage, regeneration and struc-
ural remodeling induced by deafferentation.
[d **p < 0.01 (experimental vs experimental + DEX). In panel B, representative image
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